SCHEMBL882389

SCHEMBL882389

CCOC(=O)c1sc(N)nc1C(F)(F)C(F)(F)F

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.72
HPGD P15428 4/20 0.72
CYP1A2 P05177 1/20 0.60
HSD17B10 Q99714 3/20 0.51
LMNA P02545 1/20 0.46
MAPT P10636 7/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
FBP1 P09467 1/20 0.44
KDM4E B2RXH2 5/20 0.43
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSP90AA1 P07900 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
CDC7 O00311 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL244255 0.88 ALDH1A1 (0.76) ALDH1A1HPGDCYP1A2HSD17B10LMNA
SCHEMBL10821063 0.84 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2LMNAMAPT
SCHEMBL882483 0.84 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2HSD17B10LMNA
SCHEMBL289519 0.84 ALDH1A1 (1.00) ALDH1A1HPGDCYP1A2HSD17B10LMNA
SCHEMBL6266650 0.83 ALDH1A1 (0.49) ALDH1A1HPGDCYP1A2HSD17B10LMNA
SCHEMBL882714 0.80 MAPT (0.57) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL2362831 0.77 ALDH1A1 (0.49) ALDH1A1HPGDCYP1A2HSD17B10LMNA
SCHEMBL244752 0.77 ALDH1A1 (0.73) ALDH1A1HPGDCYP1A2HSD17B10LMNA
SCHEMBL874301 0.77 ALDH1A1 (0.40) ALDH1A1HPGDCYP1A2HSD17B10MAPT
Hydrochloric Acid SCHEMBL8114168 0.75 ALDH1A1 (0.71) ALDH1A1HPGDCYP1A2HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed
WO-2012038904-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed
WO-2005041665-A1 INSECTICIDAL PERFLUOROALKYLTHIAZOLE DERIVATIVES NIPPON SODA CO. LTD. (JP) 2005-05-12 WO disclosed
US-20050090506-A1 Insecticidal perfluoroalkylthiazole derivatives NIPPON SODA CO., LTD. 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090506-A1 Insecticidal perfluoroalkylthiazole derivatives FFAR3, CYP4F3, NPFFR1 ALDH1A1 1843/4885HPGD 3799/4885CYP1A2 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.